Medications

FDA asked to consider party drug MDMA as treatment for PTSD

A California company has asked the U.S. Food and Drug Administration to approve MDMA, the active ingredient in party drugs like molly and ecstasy, as a treatment for post-traumatic stress disorder (PTSD).

Medical economics

How a novel model resolves the key pandemic policy debates

Were lockdowns an effective response to COVID-19 or would it have been better to limit intervention and let individuals spontaneously reduce their own risk of infection? Three years on from the public health emergency that ...

Arthritis & Rheumatism

How chronic knee osteoarthritis pain affects cognitive function

New research suggests that chronic knee pain caused by osteoarthritis does not cause cognitive impairment in isolation, indicating that other factors like age, pain medication and socio-economic factors are likely to play ...

page 2 from 13